Additional information
| Active substance | Solifenacin |
|---|---|
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Not routinely required |
| Also known as | YM905 |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | No significant effect |
| Trade name | VESIcare |
| Storage conditions | Store at 20-25В°C (68-77В°F) |
| Chemical name | Solifenacin succinate |
| Formula | C23H26N2O2.C4H6O4 |
| Substance class | Antimuscarinic |
| Main action | Anticholinergic agent that reduces muscle spasms of the bladder |
| Half-life | Approximately 45-68 hours |
| Dosage (medical) | Typically 5 mg once daily, can be increased to 10 mg based on response and tolerability |
| Dosage (sports) | Not applicable |
| Effects | Reduces urgency, frequency, and leakage episodes |
| Side effects | Dry mouth, constipation, blurred vision, urinary retention |
| Use in sports | None |
| Manufacturer | Astellas |
FUCIDIN 500 mg Abdi Ibragim
Clenbuterol 40 Maha Pharma
Aromaxyl Kalpa Pharmaceuticals
Stanozolol Suspension U.S.P. 50 mg Zhengzhou
Prograf 1mg Astellas Pharma
FACTIVE 320 mg Abdi Ibragim 

Reviews
There are no reviews yet.